This National Institute for Health and Care Excellence (NICE) guideline covers the care and treatment of adults, children and young people who have ulcerative colitis (UC). It aims to help professionals to provide consistent high-quality care and it highlights the importance of advice and support for people with ulcerative colitis.
Discuss the disease and associated symptoms, treatment options and monitoring:
Ulcerative colitis is a lifelong disease that is associated with significant morbidity. It can also affect a person's social and psychological wellbeing, particularly if poorly controlled. Typically, it has a relapsing–remitting pattern.
The wide choice of drug preparations and dosing regimens, the judgement required in determining the optimum timing for surgery (both electively and as an emergency) and the importance of support and information may lead to variation in practice across the UK. This guideline aims to address this variation, and to help healthcare professionals to provide consistent high-quality care. Managing ulcerative colitis in adults and children overlaps in many regards, so the guideline incorporates advice that is applicable to children and young people, which again should help to address potential inconsistencies in practice.
You can read the guideline on NICE's website.